Dementia with Lewy Bodies: Diagnosis and Management: Third Report of the DLB Consortium

McKeith 1

The third DLB Consortium members were as follows:Professor Dag Aarsland, Section of Geriatric Psychiatry, Stavanger University Hospital, Norway; Dr Louise Allan, Institute for Ageing and Health, University of Newcastle upon Tyne, UK; Dr Hiroyuki Arai, Department of Geriatric & Respiratory Medicine, Tohoku University School of Medicine, Miyagi, Japan; Dr Kunimasa Arima, National Centre Hospital for Mental, Nervous and Muscular Disorders, NCNP, Tokyo, Japan; Professor Clive Ballard,Wolfson Centre for Age-Related Diseases, King’s College, London UK; Dr Robert Barber, Akenside Unit, Newcastle General Hospital, Newcastle upon Tyne, UK; Dr Bradley Boeve, Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA; Dr Silva-Beatrice Bonelli, Departments of Neurology and Psychiatry, and Radiology, General Hospital, Linz, Austria; Professor Ubaldo Bonuccelli, Neurologia Universita' di Pisa, Milano, Italy; Jordan Bowen, Institute for Ageing and Health, University of Newcastle upon Tyne, UK; Professor Heiko Braak, J W Goethe University Clinic, Frankfurt am Main, Germany; Jennifer Bradshaw, Clinical Neuropsychology, Austin Health, West Heidelberg, Australia; Kolbjorn Bronnick, Pzychiatric Clinic, Stavanger Central Hospital, Stavanger, Norway; Dr David Burn, Institute for Ageing and Health, University of Newcastle upon Tyne, UK; Professor John Burn, Institute of Genetics, University of Newcastle upon Tyne, UK; Dr Emma Burton, Institute for Ageing and Health, University of Newcastle upon Tyne, UK; Dr Richard Camicioli, Room E223, University of Alberta, Edmonton, Canada; Sean Colloby, Institute for Ageing and Health, University of Newcastle upon Tyne, UK; Dr Durval Costa, Institute of Nuclear Medicine, HPP Medicina Molecular, SA, Porto, Portugal; Dr Jeffrey Cummings, Department of Neurology, UCLA Medical School Alzheimer's Disease Center, Los Angeles, USA; Dr Teodoro del Ser, Section of Neurology, Hospital Severo Ochoa, Madrid, Spain; Dr Kelly Del Tredici, Institute for Clinical Neuroanatomy, Johann Wolfgang Goethe University Clinic, Frankfurt, Germany; Dr Dennis Dickson, Department of Neuropathology, Mayo Clinic Jacksonville, Jacksonville, USA; Professor Bruno Dubois, Hopital La Salpetriere, Paris, France; Dr John Duda, Parkinson's Disease Research, Education and Clinical Center, Philadelphia VAMC, USA; Kathy Dujardin, Neurology & Movement Disorders, Lille University Hospital, Lille, France; Dr Keith Edwards, Alzheimer's Diagnostic & Treatment Centre, Bennington, USA; Professor Murat Emre, Department of Neurology, Istanbul University, Istanbul Faculty of Medicine, Turkey; Clive Evers, Alzheimer's Society, London, UK; Dr Howard Feldman, UBC Division of Neurology, University of British Columbia, Vancouver, Canada; Dr Doug Galasko, Dept of Neuroscience, University of California San Diego, La Jolla, USA; Dr Serge Gauthier, MCSA Alzheimer's Disease Research Unit, McGill Centre for Studies in Aging, Quebec, Canada; Dr Christopher G. Goetz, Department of Neurological Sciences, Rush University Medical Center, Chicago, USA; Dr Estrella Gómez-Tortosa, Fundación Jiménez Diaz, Servicio de Neurología, Madrid, Spain; Dr Janet Grace, Institute for Ageing & Health, University of Newcastle upon Tyne, UK; Dr Kevin Gray, University of Texas Southwestern Medical School, Dallas, USA; Dr Julian Gray, Eisai Ltd, London, UK; Professor Glenda Halliday, Prince of Wales Medical Research Institute, Sydney, Australia; Dr Ronald Hamilton, University of Pittsburgh, Pittsburgh, USA; Gerry Hammond, Janssen-Cilag, High Wycombe, UK; Professor Larry Hansen, Neuroscience and Pathology Department, University of California San Diego, San Diego, USA; Dr Antony Harding, Prince of Wales Medical Research Institute, Sydney, Australia; Professor John Hardy, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, USA; Dr Richard Harrison, Gateshead Health NHS Trust, Gateshead, UK; Kazuko Hasegawa, Sagamihari National Hospital, Salanadia, Japan; Dr Martina Hermann, Novartis Pharma AG, Basel, Switzerland; Dr Claire Hill-Venning, Nash House, Amersham Health, Amersham, UK; Professor Takeshi Iwatsubo, Department of Neuropathology & Neuroscience, University of Tokyo, Tokyo, Japan; Carmen Janvin, Section for Geriatric Hospital, Rogaland Central Hospital, Stavanger, Norway; Dr Evelyn Jaros, Department of Neuropathology, Newcastle General Hospital,Newcastle upon Tyne, UK; Professor Kurt Jellinger, Institute of Clinical Neurobiology, Vienna, Austria; Professor Raj Kalaria, Institute for Ageing and Health, University of Newcastle upon Tyne, UK; Dr Wouter Kamphorst, Dept of Neuropathology, Vrije Univeriteit Medisch Centrum, Amsterdam, The Netherlands; Dr Daniel Kaufer, Dept of Neurology CB 7025, University of North Carolina School of Medicine, Chapel Hill, USA; Linda Kelly, Chief Executive, Parkinson's Disease Society, London, UK; Professor Rose Anne Kenny, Cardiovascular Research Unit, Institute for Ageing and Health, University of Newcastle upon Tyne, UK; Professor Jae Woo Kim, Dong - A University Hospital, Busan, South Korea; Professor Amos Korczyn, Department of Neurology, Tel-Aviv University, Tel-Aviv, Israel; Professor Kenji Kosaka, Department of Psychiatry, Fukushimera Hospital, Toyohashi, Japan; Dr Anna Krygowska-Wajs, Novartis Poland,Warsaw, Poland; Dr Chong Lee, UBC Hospital, University of British Columbia, Vancouver, Canada; Dr Virginia Lee, Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine, Philadelphia, USA; Professor Andrew Lees, Reta Lila Weston Institute of Neurological Studies, Royal Free & UCL Medical School, London, UK; Dr Evelien Lemstra, Room H2-236, Academic Medical Centre, Amsterdam, The Netherlands; Dr James Leverenz, University of Washington, Seattle, USA; Dr Min Li, Neuropsychiatry Research Unit, University of Saskatchewan, Saskatoon, Saskatchewan, Canada; Professor Carol F Lippa, Memory Disorders Program, Drexel University School of Medicine, Philadelphia, USA; Dr Irene Litvan, Department of Neurology, Movement Disorder Program, University of Louisville School of Medicine, Louisville, USA; Dr Elisabet Londos, Department of Clinical Sciences, University Hospital, Malmoe, Sweden; Dr Oscar Lopez, Neuropsychology Research Program, Univeristy of Pittsburgh Medical College, Pittsburgh, USA; Professor Jim Lowe, Division of Pathology, School of Molecular Medical Sciences, University of Nottingham, Nottingham, UK; Professor Ian McKeith, Institute for Ageing and Health, University of Newcastle upon Tyne, UK; Dr Rupert McShane, Oxford Mental HealthCare Trust, Oxford, UK; Robert Meadowcroft, Parkinson’s Disease Society, London, UK; Dr Richard Law Min, Dorset Mental Health Healthcare Trust, Poole, UK; Dr Thais Minett, UNIFESP, Sao Paulo, Brazil; Professor Satoshi Minoshima, Department of Radiology, University of Washington, Seattle,Washington, USA; Professor Yoshikuni Mizuno, Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan; Dr Jose-Antonio Molina, Servicio de Neurologia, Hospital 12 de Octubre, Madrid, Spain; Dr Brit Mollenhauer, Dept of Neurology, Georg August University, Gottingen, Germany; Dr Sophie Molloy, Institute for Ageing and Health, University ofNewcastle upon Tyne, UK; Dr Hideo Mori, Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan; Dr Urs Mosimann, Institute for Ageing and Health, University of Newcastle upon Tyne, UK; Dr Elizabeta Mukaetova-Ladinska, Institute for Ageing and Health, University of Newcastle upon Tyne, UK; Dr Tatyana Muravina, Institute of Neurology RAMS, Moscow, Russia; Dr Pat Myint, Hardwyke Unit, Sedgefield Community Hospital, Sedgefield, UK; Professor Masanori Nakagawa, Department of Neurology & Gerontology, Kyoto Prefectural University of Medicine, Kyoto, Japan; Professor John O'Brien, Institute for Ageing and Health, University of Newcastle upon Tyne, UK; Dr Tomoko Oeda, Utano National Hospital, Kyoto, Japan; Dr Ivan Okamoto, UNIFESP-EPM Universidade Federal de São Paulo-Escola Paulista de Medicina São Paulo, Brazil; Professor Marco Onofrj, Neurofisiopatolgia Ospedale Civile Pescara, Milano, Italy; Dr Yasushi Osaki, Department of Cardiology, Neurology & Ageing Science, Nankoku, Japan; Dr Sanjeet Pakrasi, Institute for Ageing and Health, University of Newcastle upon Tyne, UK; Professor Florence Pasquier, Clinique Neurologique, Centre Hospitalier et Universitaire, Lille, France; Professor Elaine Perry, Institute for Ageing and Health, University of Newcastle upon Tyne, UK; Professor Robert Perry, Institute for Ageing and Health, University of Newcastle upon Tyne, UK; Dr Margaret Piggott, Institute for Ageing and Health, University of Newcastle upon Tyne, UK; Dr Irina Preobrajenskaya, Moscow Medical Academy, Moscow, Russia; Professor Niall Quinn, Department of Motor Neuroscience & Movement Disorders, Institute of Neurology, London, UK; Prof Gerhard Ransmayr, Department of Neurology & Psychiatry, Linz General Hospital, Linz, Austria; Professor Olivier Rascol, Service de Pharmacologie Clinique, Centre Hospitalier Universitaire, Toulouse Cedex, France; Dr Jill Rasmussen, Psynapse, Arlington Cottage, Dorking, UK; Dr Tamas Revesz, Division of Neuropathology, Institute of Neurology, London, UK; Dr Anna Richardson, Hope Hospital, Stockport, UK; Dr Jonathan Richardson, NNN Mental Health Trust, Newcastle, UK; Professor Martin Rossor, Dementia Research Group, The National Hospital for Neurology & Neurosurgery, London, UK; Dr Elise Rowan, Institute for Ageing and Health, University of Newcastle upon Tyne, UK; Dr Masafuchi Ryo-Yang, Isehara-Kyo-Doh Hospital, Ishehara-Shi Kanagawa, Japan; Dr Jonathan Sanders, NNN Mental Health Trust, Hexham, UK; Jan Schadrack, Novartis Pharma AG, Basel, Switzerland; Professor Jörg Schulz, Department of Neurodegeneration and Restorative Research Center of Neurological Medicine, University of Göttingen, Germany; Dr Vorapun Senanarong, Division of Neurology, Dept of Medicine, Mahidol University, Bangkok, Thailand; Dr Gabrielle Silver, Eisai Ltd, London, UK; Dr Glenn Smith, Department of Psychiatry & Psychology, Mayo Clinic Rochester, Rochester, USA; Dr Malcolm Steiger, Walton Centre for Neurology & Neurosurgery, Liverpool, UK; Professor Mitsuo Takahashi, Clinical Pharmacology, Fukuoka University, Fukuoka, Japan; Dr Alan Thomas, Institute for Ageing and Health, University of Newcastle upon Tyne, UK; Professor Markus Tolnay, Department of Neuropathology, Basel University, Basel, Switzerland; Dr Eduardo Tolosa, Neurology Service, Institut Clinic de Malaties del Sistema Nervios, Barcelona, Spain; Professor Jacques Touchon, Chu Guy De Chauliac, Montpellier, France; Dr John Trojanowski, Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine, Philadelphia, USA; Dr Debby Tsuang, University of Washington, Seattle, USA; Dr Teus van Laar, Groningen University Hospital, Groningen, The Netherlands; Dr Anoop Varma, Greater Manchester Neurosciences Centre, Manchester, UK; Dr Zuzana Walker, University of College, Epping, UK; Dr Gregor K Wenning, Department of Neurology, University Hospital Innsbruck, Innsbruck, Austria; Professor Keith Wesnes, Cognitive Drug Research Ltd, Reading, UK; Daisy Whitehead, Department of Psychology, University of Liverpool, Liverpool, UK; Professor Gordon Wilcock, Department of Care of the Elderly, University of Bristol, Bristol, UK; Professor David Williams, Regional Medical Physics Department, Sunderland Royal Hospital, Sunderland, UK; Professor Masahito Yamada, Department of Neurology & Neurobiology of Ageing, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan; Dr Mitsuhiro Yoshita, Department of Neurology & Neurobiology of Ageing, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan; Julia Zaccai, Institute of Public Health, University of Cambridge, Cambridge, UK.